Saurav Das

5PUBLICATIONS
11CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 23, 2025
Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

Ricardo D Parrondo, Saurav Das, Hanna Sledge

|Sep 05, 2024
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma.

Ricardo D Parrondo, Betsy R LaPlant, Jamie Elliott

|May 28, 2024
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities.

Sikander Ailawadhi, Yaw Adu, Ryan D Frank

|Jan 29, 2024
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.

Ricardo D Parrondo, Navnita Dutta, Betsy R LaPlant

|Nov 24, 2023
Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety.

Saurav Das, Sikander Ailawadhi, Taimur Sher

Pageof 1

Frequent Collaborators

5 joint publications

Ricardo Parrondo

4 joint publications

Sikander Ailawadhi

3 joint publications

Vivek Roy

1 joint publications

Asher A Chanan-Khan